Acceleron Pharma Inc. (XLRN): Price and Financial Metrics

Acceleron Pharma Inc. (XLRN)

Today's Latest Price: $40.97 USD

2.02 (-4.71%)

Updated Nov 15 7:39pm

Add XLRN to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 328 in Biotech

See all "A" rated Strong Buy stocks

XLRN Stock Summary

  • With a price/sales ratio of 66.18, Acceleron Pharma Inc has a higher such ratio than 97.6% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.09 for Acceleron Pharma Inc; that's greater than it is for only 7.47% of US stocks.
  • Revenue growth over the past 12 months for Acceleron Pharma Inc comes in at 175.15%, a number that bests 96.75% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Acceleron Pharma Inc are IDRA, SYBX, SRRK, AGIO, and ASMB.
  • XLRN's SEC filings can be seen here. And to visit Acceleron Pharma Inc's official web site, go to
XLRN Daily Price Range
XLRN 52-Week Price Range

XLRN Stock Price Chart More Charts

XLRN Price/Volume Stats

Current price $40.97
Prev. close $42.99
Day low $40.78
Day high $43.33
50-day MA $42.65
200-day MA $42.77
52-week high $56.91
52-week low $37.01
Volume 507,300
Avg. volume 355,570
Dividend yield N/A
Market Cap 2.17B

Acceleron Pharma Inc. (XLRN) Company Bio

Acceleron Pharma XLRN is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases. The company was founded in 2003 and is based in Cambridge, Massachusetts.

XLRN Latest News Stream

Event/Time News Detail
Loading, please wait...

XLRN Latest Social Stream

Loading social stream, please wait...

View Full XLRN Social Stream

XLRN Price Returns

1-mo -2.80%
3-mo -11.91%
6-mo -4.50%
1-year -21.56%
3-year 7.39%
5-year 22.92%
YTD -5.92%
2018 2.62%
2017 66.30%
2016 -47.66%
2015 25.15%
2014 -1.62%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 30.5158 seconds.